Prospective study of the association between NAT2 gene haplotypes and severe adverse events with sulfasalazine therapy in patients with rheumatoid arthritis

J Rheumatol. 2008 Apr;35(4):724.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / genetics*
  • Arylamine N-Acetyltransferase / genetics*
  • Female
  • Genetic Predisposition to Disease*
  • Haplotypes
  • Humans
  • Male
  • Prospective Studies
  • Sulfasalazine / adverse effects*

Substances

  • Antirheumatic Agents
  • Sulfasalazine
  • Arylamine N-Acetyltransferase
  • NAT2 protein, human